A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes-Reference-Cited by-同舟云学术

A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes

Published:2018-07-31 Issue:1 Volume:66 Page:1-9
ISSN:0895-8696
Container-title:Journal of Molecular Neuroscience
language:en
Short-container-title:J Mol Neurosci

Author:

Hu Mengming,Zhang Jun,Yang Junting,Cao Yue,Qi Jinshun^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,General Medicine

Link

http://link.springer.com/article/10.1007/s12031-018-1139-6/fulltext.html

Reference40 articles.

1. Cai Z, Hussain MD, Yan LJ (2014) Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. Int J Neurosci 124:307–321. https://doi.org/10.3109/00207454.2013.833510

2. Cattepoel S, Hanenberg M, Kulic L, Nitsch RM (2011) Chronic intranasal treatment with an anti-Abeta(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 6:e18296. https://doi.org/10.1371/journal.pone.0018296

3. Cheng L, Yin WJ, Zhang JF, Qi JS (2009) Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse 63:206–214. https://doi.org/10.1002/syn.20599

4. Cheng L et al (2017) A novel antibody targeting sequence 31-35 in amyloid beta protein attenuates Alzheimer's disease-related neuronal damage. Hippocampus 27:122–133. https://doi.org/10.1002/hipo.22676

5. Deng J et al (2015) Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3beta signaling pathway. J Neurochem 135:630–637. https://doi.org/10.1111/jnc.13351

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Antibody Fragments for Neurological Disorders: An Update;Current Neuropharmacology;2023-08-30

2. Application of Antibody Fragments Against Aβ With Emphasis on Combined Application With Nanoparticles in Alzheimer’s Disease;Frontiers in Pharmacology;2021-04-22